Mackay Memorial Hospital, Taipei
Size of patent ductus arteriosus affects the risk of aortic regurgitation
Published in Medical Device Law Weekly, March 6th, 2005
According to a study from Taiwan, "Some patients with patent ductus arteriosus (PDA) may develop new aortic regurgitation (AR) after coil occlusion. [Our] study evaluated the risk factors for the development of AR after coil occlusion of PDA."
C.H. Yu and colleagues of Mackay Memorial Hospital in Taipei described their study, "A total of 23 patients with PDA were managed with coil embolization over a three-and-a-half-year period. Three patients with preembolization AR were excluded. A post-occlusion transthoracic echocardiogram was performed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Biocoral, Inc.
European patent granted for method of preparing surgical glue - Biophan Technologies, Inc.
Two new patents issued on MRI compatibility with devices - Cornell University
Regulatory aspect of cardiovascular drug development discussed - Genaissance Pharmaceuticals, Inc.
Company obtains license to patent linking genetics to cardiac arrhythmias - ImaRx Therapeutics Inc.
Biopharmaceutical company licenses tissue destruction patent - NOBEX Corporation
Drug development company issued two patents - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
